Oppenheimer Adjusts Price Target on Regeneron Pharmaceuticals to $1,175 From $1,125
MT NewswiresApr 26 20:24
Wells Fargo Reaffirms Their Buy Rating on Regeneron (REGN)
TipRanksApr 25 17:44
Regeneron Pharmaceuticals Analyst Ratings
BenzingaApr 25 01:37
TD Cowen: Maintaining the Regeneron Pharmaceuticals (REGN.US) rating, adjusted from buy to buy rating, and the target price was adjusted from $1020.00 to $1030.00.
Zhitong FinanceApr 25 01:40
TD Cowen Maintains Buy on Regeneron Pharmaceuticals, Raises Price Target to $1030
BenzingaApr 25 01:39
TD Cowen Adjusts Regeneron Pharmaceuticals' Price Target to $1,030 From $1,020, Keeps Buy Rating
MT NewswiresApr 24 18:46
Cantor Fitzgerald: Regeneron Pharmaceuticals (REGN.US) rating was reaffirmed, adjusted from neutral to neutral, with a target price of $925.00.
Zhitong FinanceApr 17 21:30
Regeneron Pharmaceuticals Analyst Ratings
BenzingaApr 17 21:23
Cantor Fitzgerald: Regeneron Pharmaceuticals (REGN.US) rating was reaffirmed, adjusted from neutral to neutral, with a target price of $925.00.
Zhitong FinanceApr 16 02:31
Regeneron Pharmaceuticals Analyst Ratings
BenzingaApr 16 02:27
Cantor Fitzgerald Reiterates Neutral on Regeneron Pharmaceuticals, Maintains $925 Price Target
BenzingaApr 16 02:29
B of A Securities: Maintaining the Regeneron Pharmaceuticals (REGN.US) rating, adjusted from below the market to below the market rating, and the target price was adjusted from $710.00 to $720.00.
Zhitong FinanceApr 12 20:10
Regeneron Pharmaceuticals Analyst Ratings
BenzingaApr 12 20:02
Royal Bank of Canada: Regeneron Pharmaceuticals (REGN.US) rating was reaffirmed and adjusted from superior to superior market rating, with a target price of $1189.00.
Zhitong FinanceApr 9 21:50
Regeneron Pharmaceuticals Analyst Ratings
BenzingaApr 9 21:40
Morgan Stanley Raises Price Target on Regeneron Pharmaceuticals to $1,177 From $1,115, Keeps Overweight Rating
MT NewswiresApr 9 20:07
Regeneron (REGN) Receives a Buy From RBC Capital
TipRanksApr 9 18:45
Regeneron Pharmaceuticals Analyst Ratings
BenzingaApr 3 21:38
Truist Securities Maintains Buy on Regeneron Pharmaceuticals, Maintains $1135 Price Target
BenzingaApr 3 21:39
Regeneron Pharmaceuticals Analyst Ratings
BenzingaMar 26 21:34
No Data
No Data